Thermo Fisher seeks to sell part of diagnostics unit for around $4B, FT reports

Thermo Fisher (TMO) has put up for sale a portion of its diagnostics business for roughly $4B, the Financial Times’ Oliver Barnes reports. The company has reached out to private equity firms in recent weeks to gauge interest in a part of the business, which includes its microbiology unit, the author says, citing three people familiar with the matter.